Beauty Health Co

For the period ended Sep 30, 2024. Filed Nov 12, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 12, 2024

SKIN$16.77+6.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets (Unaudited)

Item 1. Financial Statements.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except for share amounts)

	September 30, 2024	December 31, 2023
ASSETS
Current assets:
Cash, cash equivalents, and restricted cash	$358,892	$523,025
Accounts receivable, net of allowances for estimated credit losses of $11,025 and $6,604 at September 30, 2024 and December 31, 2023, respectively	36,279	54,697
Inventories	73,443	91,321
Income tax receivable	399	332
Prepaid expenses and other current assets	16,034	28,877
Total current assets	485,047	698,252
Property and equipment, net	7,634	14,226
Right-of-use assets, net	14,599	12,120
Intangible assets, net	50,979	62,123
Goodwill	125,455	125,818
Deferred income tax assets, net	1,172	531
Other assets	14,662	16,043
TOTAL ASSETS	$699,548	$929,113
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$23,084	$44,768
Accrued payroll-related expenses	16,543	22,028
Lease liabilities, current	4,827	4,598
Income tax payable	1,401	2,759
Syndeo Program reserves	—	21,009
Other accrued expenses	28,093	19,846
Total current liabilities	73,948	115,008
Lease liabilities, non-current	12,093	9,319
Deferred income tax liabilities, net	1,115	702
Warrant liabilities	558	3,555
Convertible senior notes, net	551,411	738,372
Other long-term liabilities	699	2,767
Total liabilities	639,824	869,723
Commitments (Note 10)
Stockholders’ equity:
Class A Common Stock, $0.0001 par value; 320,000,000 shares authorized; 124,111,434 and 122,899,002 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively	12	12
Additional paid-in capital	561,059	541,281
Accumulated other comprehensive loss	(3,712)	(3,036)
Accumulated deficit	(497,635)	(478,867)
Total stockholders’ equity	59,724	59,390
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$699,548	$929,113

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.